Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      European Infectious Disease Diagnostics Industry to 2031 - Technological Advancements in Molecular Techniques and Infectious Diagnostic Tests Presents Opportunities

      Research and Markets Logo

      News provided by

      Research and Markets

      May 20, 2022, 06:30 ET

      Share this article

      Share this article


      DUBLIN, May 20, 2022 /PRNewswire/ -- The "Europe Infectious Disease Diagnostics Market - Country-Wise Analysis: Focus on Product, Testing Location, Infectious Disease Type, Infection Type, Technology, and End User - Analysis and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

      The Europe infectious disease diagnostics market was valued at $1,394.3 million in 2020 and is expected to reach $7,900.4 million by 2031, witnessing a CAGR of 16.48% during the forecast period 2021-2031.

      The use of infectious disease diagnostics kits, assays, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives. The increasing investments by healthcare companies to meet industry demand and the growing adoption of infectious disease diagnostics kits, tubes, and reagents among major end users are major factors propelling the growth of the Europe infectious disease diagnostics market. 

      The Europe infectious disease diagnostics market comprises well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for infectious disease diagnostics from different product types. Key market players of the Europe infectious disease diagnostics market witnessed product launch and approval, business funding, and synergistic activities from January 2018 to March 2022. The inclination of companies toward product launches suggests that companies are constantly bringing new products to the market to test viral and bacterial infections, which is primarily attributed to an increase in demand for kits and assays by end users.

      Key Companies Profiled

      Abbott, Agilent Technologies, Inc., Becton, Dickinson and Company (BD), bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd, Illumina, Inc., QIAGEN N.V., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., PerkinElmer Inc., Hologic Inc. (Mobidiag Ltd.), Abacus Diagnostica Oy, Novacyt Group, Biocartis

      Regional Segmentation

      • Europe-5 - Germany, U.K., France, Italy and Spain
      • Nordic- Denmark, Sweden, Norway and Finland
      • Baltic- Estonia, Lithuania and Latvia
      • Rest-of-Europe

      Market Growth Drivers

      • Increasing Prevalence of Infectious Diseases
      • Technological Innovation Resulting in Market Pull
      • Significant External Funding Supporting Market Growth

      Market Challenges

      • Uncertain Reimbursement Scenario
      • Lack of High Complexity Testing Centers
      • Complex Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests

      Market Opportunities

      • Massive Scope for Adoption of Infectious Disease Diagnostics in Emerging Nations
      • Technological Advancements in Molecular Techniques and Infectious Diagnostic Tests

      Key Questions Answered in the Report

      • How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment?
      • What are the major market drivers, challenges, and opportunities in the Europe infectious disease diagnostics market?
      • What are the underlying structures resulting in the emerging trends within the Europe infectious disease diagnostics market?
      • How is each segment of the Europe infectious disease diagnostics market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
      • What are the key developmental strategies implemented by the major players to sustain in the competitive market?
      • What are the key regulatory implications in developed and developing regions for molecular diagnostics?
      • Who are the leading players with significant offerings to the Europe infectious disease diagnostics market? What is the current market dominance for each of these leading players?
      • What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which infectious disease product type is anticipated to have the most promising growth?
      • What are the key applications in the Europe infectious disease diagnostics market? What are the major segments of these applications? What technologies are dominating these application segments?
      • What are the major technologies that are employed in the Europe infectious disease diagnostics market? Which is the dominating technology?
      • Who are the primary end users of the Europe infectious disease diagnostics market? Which is the fastest-growing end-user segment in the Europe infectious disease diagnostics market?
      • Who are the key manufacturers in the Europe infectious disease diagnostics market, and what are their contributions? Also, what is the growth potential of each major infectious disease diagnostics manufacturer?
      • What is the scope of the Europe infectious disease diagnostics market in the EU'5, Baltic, and Nordic regions? Which infectious disease diagnostics product and end user dominate these regions?
      • What are the emerging trends in the Europe infectious disease diagnostics market? How are these trends revolutionizing the diagnostic procedure?
      • Which technologies are anticipated to break through the current infectious diseases diagnostic regime?
      • Which companies are anticipated to be highly disruptive in the future and why?
      • What are the regulatory procedures required to unify the approval process for emerging infectious disease diagnostics? How will these enhance the reimbursement scenario?
      • What are the gaps in regularizing optimum infectious disease diagnostics adoption in regular healthcare routines? How are

      Key Topics Covered:

      1 Markets
      1.1 Product Definition
      1.1.1 Definitions
      1.1.2 Inclusion and Exclusion
      1.2 Market Overview
      1.3 Significant Technologies in Infectious Disease Diagnostics
      1.4 Classification of Infectious Disease Diagnostics
      1.5 Europe Footprint
      1.6 Market Dynamics
      1.6.1 Impact Analysis
      1.6.2 Market Drivers
      1.6.2.1 Increasing Prevalence of Infectious Diseases
      1.6.2.2 Technological Innovation Resulting in Market Pull
      1.6.2.3 Significant External Funding Supporting Market Growth
      1.6.3 Market Restraints
      1.6.3.1 Uncertain Reimbursement Scenario
      1.6.3.2 Lack of High Complexity Testing Centers
      1.6.3.3 Complex Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests
      1.6.4 Market Opportunities
      1.6.4.1 Massive Scope for Adoption of Infectious Disease Diagnostics in Emerging Nations
      1.6.4.2 Technological Advancements in Molecular Techniques and Infectious Diagnostic Tests
      1.7 COVID-19 Impact on Europe Infectious Disease Diagnostics Market
      1.7.1 COVID-19 Impact on Infectious Disease Diagnostics Market Size
      1.7.2 Realistic Growth Scenario
      1.7.3 Optimistic Growth Scenario
      1.7.4 Disruption in Europe Infectious Disease Diagnostics Market Due to COVID-19
      1.8 Competitive Landscape
      1.8.1 Acquisitions
      1.8.2 Synergistic Activities
      1.8.3 Product Launches and Approvals
      1.8.4 Business Expansion Activities
      1.8.5 Market-Share Analysis (by Company)
      1.8.6 Growth-Share Analysis (by Technology)
      1.9 Industry Insights
      1.9.1 Legal Requirements and Framework in Europe

      2 Products
      2.1 Overview
      2.1.1 System
      2.1.2 Kits and Reagents
      2.1.3 Software

      3 Testing Location
      3.1 Overview
      3.1.1 Laboratory Testing
      3.1.2 Point-of-Care Testing

      4 Technology
      4.1 Overview
      4.1.1 Polymerase Chain Reaction (PCR)
      4.1.1.1 Real-Time PCR (RT-PCR)
      4.1.1.2 Digital PCR (d-PCR)
      4.1.2 Next-Generation Sequencing
      4.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
      4.1.4 Microarray
      4.1.5 In-Situ Hybridization (ISH)
      4.1.6 Immunodiagnostics
      4.1.7 Other Technologies

      5 Infectious Disease Type
      5.1 Overview
      5.1.1 Bacterial Infectious Diseases
      5.1.2 Viral Infectious Diseases
      5.1.3 Fungal Infectious Diseases
      5.1.4 Other Infectious Diseases

      6 Infection Type
      6.1 Overview
      6.1.1 Respiratory Infections
      6.1.1.1 COVID-19 Infection
      6.1.1.2 Influenza A and B
      6.1.1.3 Respiratory Syncytial Virus
      6.1.1.4 Mycoplasma Infections
      6.1.1.5 Pertussis Infections
      6.1.1.6 Other Respiratory Infections
      6.1.2 Hospital-Acquired Infections (HAIs)
      6.1.3 Sexually Transmitted Infections (STIs)
      6.1.3.1 Hepatitis B
      6.1.3.2 HIV-AIDS
      6.1.3.3 Human Papillomavirus (HPV)
      6.1.3.4 Neisseria Gonorrhea
      6.1.3.5 Other STIs
      6.1.4 Other Infections

      7 End User
      7.1 Overview
      7.1.1 Hospitals
      7.1.1.1 Hospitals (by Respiratory Infections)
      7.1.1.1.1 Hospitals (Influenza A and B)
      7.1.1.1.2 Hospitals (COVID-19 Infection)
      7.1.1.1.3 Hospitals (Respiratory Syncytial Virus (RSV))
      7.1.1.1.4 Hospitals (Mycoplasma Infections)
      7.1.1.1.5 Hospitals (Pertussis Infections)
      7.1.1.1.6 Hospitals (Other Respiratory Infections)
      7.1.1.2 Hospitals (by Sexually Transmitted Infections (STIs))
      7.1.1.2.1 Hospitals (Hepatitis B)
      7.1.1.2.2 Hospitals (HIV-AIDS)
      7.1.1.2.3 Hospitals (HPV)
      7.1.1.2.4 Hospitals (Neisseria Gonorrhea)
      7.1.1.2.5 Hospitals (Other STIs)
      7.1.2 Diagnostic Centers
      7.1.3 Out-Patient Clinics/General Practitioners
      7.1.4 Research Laboratories
      7.1.5 Other End Users

      8 Regions

      9 Company Profiles
      9.1 Overview
      9.2 Abbott
      9.2.1 Company Overview
      9.2.2 Role of Abbott in the Europe Infectious Disease Diagnostics Market
      9.2.3 Key Competitors of the Company
      9.2.4 Key Customers of the Company
      9.2.5 Corporate Strategies
      9.2.6 Business Strategies
      9.2.7 Financials
      9.2.8 Key Insights about the Financial Health of the Company
      9.2.9 SWOT Analysis
      9.3 Agilent Technologies, Inc.
      9.4 Becton, Dickinson and Company (BD)
      9.5 bioMerieux SA
      9.6 Bio-Rad Laboratories, Inc.
      9.7 Danaher
      9.8 F. Hoffmann-La Roche Ltd
      9.9 Illumina, Inc.
      9.1 QIAGEN N.V.
      9.11 Siemens Healthcare GmbH
      9.12 Thermo Fisher Scientific Inc.
      9.13 PerkinElmer Inc.
      9.14 Hologic Inc. (Mobidiag Ltd.)
      9.15 Abacus Diagnostica Oy
      9.16 Novacyt Group.
      9.17 Biocartis

      For more information about this report visit https://www.researchandmarkets.com/r/8dl8ko

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.